Mean platelet volume: Difference between revisions
Content deleted Content added
m Dating maintenance tags: {{Medref}} |
Ozzie10aaaa (talk | contribs) m Cleaned up using AutoEd |
||
| Line 18: | Line 18: | ||
=== Decreased MPV === |
=== Decreased MPV === |
||
* Cytotoxic [[chemotherapy]] |
* Cytotoxic [[chemotherapy]] |
||
* [[Splenomegaly|Hypersplenism]] |
* [[Splenomegaly|Hypersplenism]] |
||
* [[Thrombocytosis|Reactive thrombocytosis]] |
* [[Thrombocytosis|Reactive thrombocytosis]] |
||
* [[Iron-deficiency anemia]] |
* [[Iron-deficiency anemia]] |
||
* [[Gilbert's syndrome]] |
* [[Gilbert's syndrome]] |
||
* [[HIV/AIDS|Acquired Immunodeficiency Syndrome]] ([[HIV/AIDS|AIDS]]) |
* [[HIV/AIDS|Acquired Immunodeficiency Syndrome]] ([[HIV/AIDS|AIDS]]) |
||
* [[Wiskott–Aldrich syndrome]] |
* [[Wiskott–Aldrich syndrome]] |
||
* [[X linked thrombocytopenia]] |
* [[X linked thrombocytopenia]] |
||
* [[Crohn's disease]] |
* [[Crohn's disease]] |
||
| Line 30: | Line 30: | ||
=== Increased MPV === |
=== Increased MPV === |
||
* [[Immune thrombocytopenic purpura|Immune thrombocytopenia]] |
* [[Immune thrombocytopenic purpura|Immune thrombocytopenia]] |
||
* [[Disseminated intravascular coagulation]] |
* [[Disseminated intravascular coagulation]] |
||
* [[Myeloproliferative disorders]] |
* [[Myeloproliferative disorders]] |
||
* Administration of [[erythropoietin]] / [[thrombopoietin]] |
* Administration of [[erythropoietin]] / [[thrombopoietin]] |
||
* Recovery from transient [[aplastic anemia|hypoplasia]] |
* Recovery from transient [[aplastic anemia|hypoplasia]] |
||
* [[Gray platelet syndrome]] |
* [[Gray platelet syndrome]] |
||
* GATA-1 mutation |
* GATA-1 mutation |
||
* vWD Type 2B |
* vWD Type 2B |
||
* Platelet Type vWD |
* Platelet Type vWD |
||
* [[Paris-Trousseau syndrome]] |
* [[Paris-Trousseau syndrome]] |
||
* Mediterranean macrothrombocytopenia |
* Mediterranean macrothrombocytopenia |
||
* [[Bernard–Soulier syndrome]]<ref>{{Cite web | date = 7 August 2020 | vauthors = Geil GD | veditors = Yaish HM |url=https://emedicine.staging.medscape.com/article/954877-workup|title=Bernard-Soulier Syndrome Workup: Approach Considerations|website=emedicine.staging.medscape.com|language=en|access-date=2018-02-22}}</ref> |
* [[Bernard–Soulier syndrome]]<ref>{{Cite web | date = 7 August 2020 | vauthors = Geil GD | veditors = Yaish HM |url=https://emedicine.staging.medscape.com/article/954877-workup|title=Bernard-Soulier Syndrome Workup: Approach Considerations|website=emedicine.staging.medscape.com|language=en|access-date=2018-02-22}}</ref> |
||
* MYH9-related disorders |
* MYH9-related disorders |
||
* 21q11 deletion syndrome |
* 21q11 deletion syndrome |
||
* [[Chronic myelogenous leukemia]] |
* [[Chronic myelogenous leukemia]] |
||
* Post-[[splenectomy]] |
* Post-[[splenectomy]] |
||
* [[Vasculitis]] |
* [[Vasculitis]] |
||
* [[Megaloblastic anemia]]<ref>{{Cite book|url=https://books.google.com/books?id=3PJVLH1NmQAC&q=megaloblastic+anemia+has+high+MPV&pg=PA814|title=Clinical Laboratory Medicine| vauthors = McClatchey KD |date=2002|publisher=Lippincott Williams & Wilkins|isbn=9780683307511|language=en}}</ref> |
* [[Megaloblastic anemia]]<ref>{{Cite book|url=https://books.google.com/books?id=3PJVLH1NmQAC&q=megaloblastic+anemia+has+high+MPV&pg=PA814|title=Clinical Laboratory Medicine| vauthors = McClatchey KD |date=2002|publisher=Lippincott Williams & Wilkins|isbn=9780683307511|language=en}}</ref> |
||
* [[Diabetes mellitus]] |
* [[Diabetes mellitus]] |
||
* [[Pre-eclampsia]] |
* [[Pre-eclampsia]] |
||
* [[Chronic kidney disease]] |
* [[Chronic kidney disease]] |
||
* [[Respiratory disease]]s |
* [[Respiratory disease]]s |
||
* [[Thrombocytopenia]] secondary to [[sepsis]] |
* [[Thrombocytopenia]] secondary to [[sepsis]] |
||
* [[Hyperthyroidism]] |
* [[Hyperthyroidism]] |
||
* [[Hypothyroidism]] |
* [[Hypothyroidism]] |
||
* [[Myocardial infarction]] |
* [[Myocardial infarction]] |
||
* [[Artificial heart valve]]s |
* [[Artificial heart valve]]s |
||
* [[Bleeding|Massive hemorrhage]] |
* [[Bleeding|Massive hemorrhage]] |
||
== Inherited thrombocytopenia with normal MPV == |
== Inherited thrombocytopenia with normal MPV == |
||
* [https://books.google.com/books?id=yF5WQdAcdfcC&pg=PA974&dq=atrus+syndrome&hl=en&sa=X&ved=0ahUKEwj258T4orrZAhWunOAKHblrB1UQ6AEINDAC#v=onepage&q=atrus%20syndrome&f=false ATRUS Syndrome] |
* [https://books.google.com/books?id=yF5WQdAcdfcC&pg=PA974&dq=atrus+syndrome&hl=en&sa=X&ved=0ahUKEwj258T4orrZAhWunOAKHblrB1UQ6AEINDAC#v=onepage&q=atrus%20syndrome&f=false ATRUS Syndrome] |
||
* [http://www.omim.org/entry/188000 Thrombocytopenia 2 (THC2)] |
* [http://www.omim.org/entry/188000 Thrombocytopenia 2 (THC2)] |
||
* [[Congenital amegakaryocytic thrombocytopenia]] |
* [[Congenital amegakaryocytic thrombocytopenia]] |
||
* [[TAR syndrome]] |
* [[TAR syndrome]] |
||
* Familial platelet disorder with predisposition to AML |
* Familial platelet disorder with predisposition to AML |
||
Revision as of 22:32, 23 April 2022
 | This article needs more reliable medical references for verification or relies too heavily on primary sources. (November 2021) |  |
| Mean platelet volume | |
|---|---|
| Purpose | can be used to make inferences about platelet production in bone marrow or platelet destruction problems |
Mean platelet volume (MPV) is a machine-calculated measurement of the average size of platelets found in blood and is typically included in blood tests as part of the CBC. Since the average platelet size is larger when the body is producing increased numbers of platelets, the MPV test results can be used to make inferences about platelet production in bone marrow or platelet destruction problems.[1]
MPV may be higher when there is destruction of platelets. This may be seen in immune thrombocytopenic purpura (ITP), myeloproliferative diseases and Bernard–Soulier syndrome. It may also be related to pre-eclampsia and recovery from transient hypoplasia.[2]
Abnormally low MPV values may correlate with thrombocytopenia when it is due to impaired production of megakaryocytes in the bone marrow, such as in aplastic anemia. A low MPV may indicate inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis.[3] A high MPV is also a bad prognostic marker in patients with sepsis or septic shock.[4][5] In addition, low MPV may correlate with abnormally small platelet size, sometimes a symptom of a spectrum referred to as Wiskott–Aldrich syndrome (WAS),[6] caused by a genetic mutation of the WAS gene.
Sample for MPV testing is obtained in a Lavender-Top EDTA tube. A typical range of platelet volumes is 9.4–12.3 fL[7] (femtolitre), equivalent to spheres 2.65 to 2.9 µm in diameter.
Conditions associated with altered MPV
Decreased MPV
- Cytotoxic chemotherapy
- Hypersplenism
- Reactive thrombocytosis
- Iron-deficiency anemia
- Gilbert's syndrome
- Acquired Immunodeficiency Syndrome (AIDS)
- Wiskott–Aldrich syndrome
- X linked thrombocytopenia
- Crohn's disease
- Ulcerative colitis
- Aplastic anemia
Increased MPV
- Immune thrombocytopenia
- Disseminated intravascular coagulation
- Myeloproliferative disorders
- Administration of erythropoietin / thrombopoietin
- Recovery from transient hypoplasia
- Gray platelet syndrome
- GATA-1 mutation
- vWD Type 2B
- Platelet Type vWD
- Paris-Trousseau syndrome
- Mediterranean macrothrombocytopenia
- Bernard–Soulier syndrome[8]
- MYH9-related disorders
- 21q11 deletion syndrome
- Chronic myelogenous leukemia
- Post-splenectomy
- Vasculitis
- Megaloblastic anemia[9]
- Diabetes mellitus
- Pre-eclampsia
- Chronic kidney disease
- Respiratory diseases
- Thrombocytopenia secondary to sepsis
- Hyperthyroidism
- Hypothyroidism
- Myocardial infarction
- Artificial heart valves
- Massive hemorrhage
Inherited thrombocytopenia with normal MPV
- ATRUS Syndrome
- Thrombocytopenia 2 (THC2)
- Congenital amegakaryocytic thrombocytopenia
- TAR syndrome
- Familial platelet disorder with predisposition to AML
References
- ^ "Complete Blood Count (CBC)". Lab Tests Online.
- ^ Lippi G, Filippozzi L, Salvagno GL, Montagnana M, Franchini M, Guidi GC, Targher G (September 2009). "Increased mean platelet volume in patients with acute coronary syndromes". Archives of Pathology & Laboratory Medicine. 133 (9): 1441–3. doi:10.5858/133.9.1441. PMID 19722752.
- ^ Liu S, Ren J, Han G, Wang G, Gu G, Xia Q, Li J (October 2012). "Mean platelet volume: a controversial marker of disease activity in Crohn's disease". European Journal of Medical Research. 17: 27. doi:10.1186/2047-783x-17-27. PMC 3519557. PMID 23058104.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ^ Mangalesh S, Dudani S, Malik A (March 2021). "Platelet Indices and Their Kinetics Predict Mortality in Patients of Sepsis". Indian Journal of Hematology & Blood Transfusion: 1–9. doi:10.1007/s12288-021-01411-2. PMC 7988247. PMID 33776267.
- ^ Gao Y, Li Y, Yu X, Guo S, Ji X, Sun T, et al. (2014-08-13). Stover CM (ed.). "The impact of various platelet indices as prognostic markers of septic shock". PLOS ONE. 9 (8): e103761. Bibcode:2014PLoSO...9j3761G. doi:10.1371/journal.pone.0103761. PMC 4131909. PMID 25118886.
- ^ "Wiskott-Aldrich Syndrome". Immune Deficiency Foundation. Retrieved 2019-03-03.
- ^ "CBC (Complete Blood Count), Blood". www.healthcare.uiowa.edu. Retrieved 2018-02-22.
- ^ Geil GD (7 August 2020). Yaish HM (ed.). "Bernard-Soulier Syndrome Workup: Approach Considerations". emedicine.staging.medscape.com. Retrieved 2018-02-22.
- ^ McClatchey KD (2002). Clinical Laboratory Medicine. Lippincott Williams & Wilkins. ISBN 9780683307511.
Further reading
- Davis PD, Nabili SN (27 August 2020). Shiel Jr WC (ed.). "What Is Thrombocytopenia (Low Platelet Count)?". Medicinenet.com.
- Slavka G, Perkmann T, Haslacher H, Greisenegger S, Marsik C, Wagner OF, Endler G (May 2011). "Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease". Arteriosclerosis, Thrombosis, and Vascular Biology. 31 (5): 1215–8. doi:10.1161/ATVBAHA.110.221788. PMID 21330610.
- Bessman JD, Gilmer PR, Gardner FH (1985). "Use of mean platelet volume improves detection of platelet disorders". Blood Cells. 11 (1): 127–35. PMID 4074887.